Efficacy and safety of colistin plus beta-lactams for bone and joint infection caused by fluoroquinolone-resistant gram-negative bacilli: a prospective multicenter study-Reference-Cited by-同舟云学术

Efficacy and safety of colistin plus beta-lactams for bone and joint infection caused by fluoroquinolone-resistant gram-negative bacilli: a prospective multicenter study

Published:2024-09-09 Issue: Volume: Page:
ISSN:0300-8126
Container-title:Infection
language:en
Short-container-title:Infection

Author:

Mancheño-Losa Mikel,Murillo Oscar,Benavent Eva,Sorlí Luisa,Riera Melchor,Cobo Javier,Benito Natividad,Morata Laura,Ribera Alba,Sobrino Beatriz,Fernández-Sampedro Marta,Múñez Elena,Bahamonde Alberto,Barbero José María,del Toro Mª Dolores^ORCID,Villa Jenifer,Rigo-Bonnin Raül,Luque Sonia,García-Luque Isabel,Oliver Antonio,Esteban Jaime,Lora-Tamayo Jaime

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s15010-024-02379-7.pdf

Reference45 articles.

1. Benito N, Franco M, Ribera A, Soriano A, Rodriguez-Pardo D, Sorlí L, et al. Time trends in the aetiology of prosthetic joint infections: a multicentre cohort study. Clin Microbiol Infect. 2016;22:732.e1-732.e8.

2. Zimmerli W. Prosthetic-joint infections. N Engl J Med. 2004;351:1645–54.

3. Rodríguez-Pardo D, Pigrau C, Lora-Tamayo J, Soriano A, Del Toro MD, Cobo J, et al. Gram-negative prosthetic joint infection: outcome of a debridement, antibiotics and implant retention approach: a large multicentre study. Clin Microbiol Infect. 2014;20:O911–9.

4. Magiorakos A-P, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268–81.

5. Zimmerli W. Bone and joint infections: from microbiology to diagnostics and treatment. 2nd ed. Hoboken, NJ, USA: Wiley-Blackwell; 2021.